Current Pharmaceutical Biotechnology This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Enhancement in Biological Availability of Vitamins by Nano-engineering and its Applications: An Update
Curr Pharm Biotechnol. 2023 Nov 2. doi: 10.2174/0113892010251234231025085759. Online ahead of print.ABSTRACTVitamin nano-engineering has been accomplished by synthesizing various nanostructures to improve their stability, bioavailability, shelf life, and functioning. This review provides a detailed description of recent advances in the art of encapsulation with high efficiency through the use of practical and logistic nano-engineering techniques such as nanofibres, nanogels, nanobeads, nanotubes, nanoparticles, nanoliposomes, and many other nanostructures. To demonstrate the interaction of molecules with nano-forms, the bi...
Source: Current Pharmaceutical Biotechnology - November 8, 2023 Category: Biotechnology Authors: Sadhna Mishra Shalini Sahani Shikha Pandhi Arvind Kumar Dipendra Kumar Mahato Pradeep Kumar Kaustubh Chandrakant Khaire Ashutosh Rai Source Type: research

Insights into the Mechanism of Osteoporosis and the Available Treatment Options
Curr Pharm Biotechnol. 2023 Nov 2. doi: 10.2174/0113892010273783231027073117. Online ahead of print.ABSTRACTOsteoporosis, one of the most prevalent bone illnesses, majorly affects postmenopausal women and men over 50 years of age. Osteoporosis is associated with an increased susceptibility to fragility fractures and can result in persistent pain and significant impairment in affected individuals. The primary method for diagnosing osteoporosis involves the assessment of bone mineral density (BMD) through the utilisation of dual energy x-ray absorptiometry (DEXA). The integration of a fracture risk assessment algorithm with ...
Source: Current Pharmaceutical Biotechnology - November 8, 2023 Category: Biotechnology Authors: Rajeshwari Muniyasamy I Manjubala Source Type: research

Cubosomes: An Emerging and Promising Drug Delivery System for Enhancing Cancer Therapy
Curr Pharm Biotechnol. 2023 Oct 27. doi: 10.2174/0113892010257937231025065352. Online ahead of print.ABSTRACTCancer and other diseases can be treated with cubosomes, which are lyotropic nonlamellar liquid crystalline nanoparticles (LCNs). These cubosomes can potentially be a highly versatile carrier with theranostic efficacy, as they can be ingested, applied topically, or injected intravenously. Recent years have seen substantial progress in the synthesis, characterization, regulation of drug release patterns, and target selectivity of loaded anticancer bioactive compounds. However, its use in clinical settings has been sl...
Source: Current Pharmaceutical Biotechnology - November 6, 2023 Category: Biotechnology Authors: Smita Singh Kapil Sachan Suryakant Verma Nidhi Singh Pranjal Kumar Singh Source Type: research

N-acetylcysteine Attenuates Cigarette Smoke-induced Alveolar Epithelial Cell Apoptosis through Reactive Oxygen Species Depletion and Glutathione Replenish In vivo and In vitro
CONCLUSION: Our study confirmed that NAC can attenuate CS-induced AEC apoptosis via alleviating ROS-mediated ER stress and mitochondrial dysfunction pathway, and the mechanism was found to be related to replenishing the cellular GSH content.PMID:37921125 | DOI:10.2174/0113892010257526231019143524 (Source: Current Pharmaceutical Biotechnology)
Source: Current Pharmaceutical Biotechnology - November 3, 2023 Category: Biotechnology Authors: Jie Zhao Mi Han Yange Tian Peng Zhao Xuefang Liu Haoran Dong Suxiang Feng Jiansheng Li Source Type: research